Mm. Doherty et Ks. Pang, Route-dependent metabolism of morphine in the vascularly perfused rat small intestine preparation, PHARM RES, 17(3), 2000, pp. 291-298
Purpose. 1. To compare the disposition of tracer morphine ([H-3]M) followin
g systemic and intraduodenal administration in the recirculating, rat small
intestine preparation in absence or presence of verapamil (V), an inhibito
r of P-glycoprotein, 2. To develop a physiological model to explain the obs
ervations.
Methods. A bolus dose of [H-3]M was added to the reservoir or injected into
the duodenum of the rat small intestine preparation. V (200 mu M in reserv
oir) was either absent (control studies) or present. Intestinal microsomal,
incubation studies were performed to evaluate the effect of V on morphine
glucuronidation.
Results. After systemic administration, [H-3]M was not metabolized but was
exsorbed into lumen. By contrast, both [H-3]M and the 3 beta-glucuronide me
tabolite, [H-3]M3G, appeared in reservoir and lumen after intraduodenal adm
inistration. A physiologically-based model that encompassed absorption, met
abolism and secretion was able to describe the route-dependent glucuronidat
ion of M. The presence of V resulted in diminished levels of M3G in perfusa
te and lumen and mirrored the observation of decreased glucuronidation in m
icrosomal incubations. Verapamil appeared to be an inhibitor of glucuronida
tion and not secretion of M.
Conclusions. M was secreted and absorbed by the rat small intestine. Route-
dependent glucuronidation of hi was explained by physiological modeling whe
n M was poorly partitioned in intestinal tissue, with a low influx clearanc
e from blood and a even poorer efflux clearance from tissue. The poor efflu
x rendered a much greater metabolism of M that was initially absorbed from
the lumen. V increased the extent of M absorption through inhibition of M g
lucuronidation.